Uta Margareta Demel

5PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 12, 2026
Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

|Jan 22, 2026
Aberrant SUMOylation Restricts the Targetable Cancer Immunopeptidome.

Uta M Demel, Anna Meurer, Badeel Kh Q Zaghla

|Oct 20, 2025
Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.

M Korenkov, J Liebaert, S Yousefian

|Feb 20, 2024
Activation of gp130 signaling in T cells drives T<sub>H</sub>17-mediated multi-organ autoimmunity.

Francis Baumgartner, Stefanos A Bamopoulos, Laura Faletti

|Jul 24, 2023
Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs the DNA damage response.

Le Zhang, Matthias Wirth, Upayan Patra

Pageof 1

Frequent Collaborators

5 joint publications

Ulrich Keller

2 joint publications

Simon Haas

2 joint publications

Antonia Busse

1 joint publications

M Korenkov